Cancer Treatment Cost in India (2026): What 43,000+ Real Patients Actually Paid
Cancer treatment in India costs between ₹2 lakh and ₹25 lakh for most patients, depending on the cancer type, stage, treatment protocol, and hospital. Based on 43,000+ medical fundraising campaigns on Milaap, India’s largest crowdfunding platform, the median cancer treatment cost is ₹5 lakh, meaning half of all families needed less than this amount and half needed more. The average, pulled up by complex cases, is ₹8.4 lakh. These are not hospital rate-card estimates. They are the actual amounts real families needed to raise to pay for treatment.
⚡ Most government schemes require you to apply before initiating treatment. Read this guide before your first hospital visit.
What Drives the Cost of Cancer Treatment in India
No two cancer treatment journeys cost the same. The final figure depends on a combination of factors, some within your control and most not.
Type and stage of cancer is the single biggest cost driver. According to the Indian Council of Medical Research (ICMR), the most common cancers in India are oral, breast, cervical, lung, and stomach cancers. Blood cancers such as leukaemia and lymphoma typically cost more per cycle than solid tumours. Stage 4 cancers require systemic treatment that continues indefinitely, while early-stage cancers can often be treated with a finite course of surgery and radiation.
Treatment protocol, whether it involves surgery alone, surgery plus chemotherapy, or a combination of all three modalities, determines the number of visits, admissions, and drug costs. The National Cancer Grid (NCG) publishes evidence-based treatment guidelines for each cancer type in India, which is the most reliable reference for understanding what a standard protocol involves. A breast cancer patient who needs a lumpectomy followed by six cycles of AC-T chemotherapy and 25 radiation sessions faces a very different financial journey from one who needs a mastectomy followed only by hormone therapy.
Hospital tier has a direct and measurable impact. Our data shows a 2x gap in median cost between government-aided cancer hospitals, which come in at ₹5 lakh, and premium private chains like Medanta or Max, which come in at ₹10 lakh. The gap in actual treatment outcomes is often smaller than the gap in cost, which is something we will come back to in the hospital section.
City of treatment matters even when hospital tier is controlled for. Chemotherapy in Mumbai costs 20 to 30% more per cycle than the same protocol in Ahmedabad or Hyderabad, according to HCG’s 2026 benchmarking data. Our own dataset confirms this. Gurugram’s median is ₹10 lakh against Madurai’s ₹4 lakh.
Drug type, from generic cytotoxics to branded biologics, can swing a single cycle’s cost by 10x. Generic cyclophosphamide costs far less than rituximab or trastuzumab. India’s Drug Price Control Order (DPCO) caps prices on essential cancer medicines, and many chemotherapy drugs appear on the National List of Essential Medicines (NLEM), which means they are available at regulated rates. Patients should always ask their oncologist whether a biosimilar or generic equivalent is clinically appropriate for their specific protocol.
Duration of treatment is consistently underestimated. A single hospitalisation for surgery is a one-time cost. Chemotherapy runs 4 to 8 cycles. Immunotherapy or targeted therapy can run for years. The campaign amount a family sets at diagnosis often reflects only the first phase of what becomes a much longer financial journey.
Cost by Treatment Type
Chemotherapy
Chemotherapy is the most common cancer treatment we see families fundraise for on our platform. A single cycle costs between ₹15,000 and ₹2,00,000 depending on the drugs used. Conventional cytotoxic agents sit at the lower end; targeted biologics are at the top.
The per-cycle cost by regimen gives a more useful picture than a flat range:
| Regimen | Cancer type | Estimated cost per cycle |
|---|---|---|
| AC-T | Breast | ₹20,000 to ₹60,000 |
| FOLFOX / CAPOX | Colorectal | ₹15,000 to ₹50,000 |
| R-CHOP | Lymphoma | ₹30,000 to ₹80,000 |
| Carboplatin + Paclitaxel | Lung / Ovarian | ₹25,000 to ₹70,000 |
| ABVD | Hodgkin Lymphoma | ₹15,000 to ₹45,000 |
Source: Regimen costs from HCG Oncology 2026 guide and standard oncology protocol literature.
Most chemotherapy courses involve 6 to 8 cycles administered every 3 weeks. A full course of AC-T for breast cancer, for example, might cost ₹1.2 lakh to ₹4.8 lakh for the drugs alone, before nursing charges, anti-nausea medication, blood monitoring tests, and growth-factor injections that often add ₹5,000 to ₹30,000 per cycle on top.
Total chemotherapy cost: ₹2.5 lakh to ₹25 lakh for most solid tumour protocols.
One thing we consistently see families miss: the drug quote is not the treatment quote. Always ask your hospital for an itemised estimate that includes support medications, monitoring tests, day-care charges, and physician fees, not just the chemotherapy drug cost alone.
Surgery
Surgery is often the first-line treatment for solid tumours detected early. Costs vary significantly by the type of procedure and its complexity.
| Surgery type | Approximate cost |
|---|---|
| Breast cancer (lumpectomy) | ₹1.5 to ₹3 lakh |
| Breast cancer (mastectomy) | ₹2 to ₹4 lakh |
| Colorectal cancer surgery | ₹2 to ₹5 lakh |
| Thyroid cancer surgery | ₹1.5 to ₹3 lakh |
| Brain tumour surgery | ₹3 to ₹6 lakh |
| Lung cancer resection | ₹3 to ₹7 lakh |
| Laparoscopic or robotic procedures | Add ₹1 to ₹2 lakh to the above |
Source: Cost ranges cross-referenced from GS Hospitals cancer treatment guide, Star Health treatment breakdown, and Milaap campaign data.
These figures include the surgery, anaesthesia, a standard 3 to 5 day hospital stay, and initial post-operative care. They do not include pre-operative diagnostics, pathology, or subsequent treatment courses.
Radiation Therapy
Radiation is used for curative, adjuvant (post-surgery), and palliative purposes. The type of technology creates wide cost variation:
| Radiation type | Cost range |
|---|---|
| Conventional (External Beam) | ₹1.2 to ₹2.5 lakh |
| IMRT / IGRT (Intensity Modulated) | ₹2.5 to ₹5 lakh |
| Stereotactic Radiosurgery (CyberKnife or Gamma Knife) | ₹3.5 to ₹6.5 lakh |
| Proton Beam Therapy | ₹12 to ₹20 lakh |
Source: Radiation cost ranges from Star Health’s treatment cost breakdown and GS Hospitals guide. Proton therapy availability verified via Apollo Proton Cancer Centre.
A standard radiation course involves 20 to 35 daily sessions over 4 to 7 weeks. Proton therapy, available at Apollo Proton Cancer Centre in Chennai and a handful of other centres, is significantly more expensive but may offer clinical advantages for certain cancers, particularly paediatric cases and tumours near the base of skull or spine. The Atomic Energy Regulatory Board (AERB) regulates all radiation therapy facilities in India.
Immunotherapy and Targeted Therapy
These newer treatment categories are increasingly common in the campaigns we see, and they carry substantially higher costs than conventional chemotherapy.
Immunotherapy, including checkpoint inhibitors like pembrolizumab and nivolumab, costs ₹1.5 lakh to ₹4 lakh per session. Most regimens involve sessions every 3 to 6 weeks, often continuing for 2 years or longer. Annual cost: ₹20 lakh to ₹50 lakh. Government price controls have brought some biosimilar checkpoint inhibitors down to ₹30,000 to ₹80,000 per session at certain centres.
Targeted therapy, such as imatinib for CML, trastuzumab for HER2-positive breast cancer, or osimertinib for EGFR-positive lung cancer, is taken as daily oral medication or monthly infusions. Monthly cost runs ₹80,000 to ₹2.5 lakh depending on the molecule. Generic versions of some targeted agents are available in India at a fraction of the originator price. Ask your oncologist specifically about this because hospitals do not always volunteer the information.
Bone Marrow Transplant (BMT)
BMT is the most expensive cancer treatment category in our dataset by a significant margin. Families fundraising for BMT on Milaap set goals well above the ₹5 lakh median we see for most cancer types.
| BMT type | Approximate total cost |
|---|---|
| Autologous (own stem cells) | ₹12 to ₹20 lakh |
| Allogeneic, matched sibling donor | ₹20 to ₹35 lakh |
| Allogeneic, unrelated or matched donor | ₹25 to ₹50 lakh |
| Haploidentical | ₹18 to ₹30 lakh |
Source: BMT cost ranges are based on data published by the Indian Society of Blood and Marrow Transplantation (ISBMT) and reported in campaigns on our platform. Costs at government centres (AIIMS, CMC Vellore, Tata Medical Center) are significantly lower than at private facilities.
These totals include pre-transplant conditioning chemotherapy, the transplant procedure, a 4 to 6 week hospital stay, and initial post-transplant medication. They do not include the 6 to 12 months of post-transplant monitoring, graft-versus-host disease (GVHD) treatment, or infection management that can add several lakhs more.
Cancer Treatment Cost by City: What We Found in Our Data
The table below is built from 43000+ real fundraisers. We have listed the 20 cities most represented in our data, which also happen to be the cities where most Indian cancer patients seek treatment.
| City | Median treatment cost |
|---|---|
| Mumbai | ₹5,00,000 |
| Delhi | ₹6,00,000 |
| Bengaluru | ₹5,00,000 |
| Kolkata | ₹5,00,000 |
| Hyderabad | ₹6,00,000 |
| Chennai | ₹5,00,000 |
| Vellore | ₹8,00,000 |
| Pune | ₹5,00,000 |
| Coimbatore | ₹5,00,000 |
| Lucknow | ₹5,00,000 |
| Bhubaneswar | ₹5,00,000 |
| Patna | ₹5,00,000 |
| Varanasi | ₹5,00,000 |
| Nagpur | ₹5,00,000 |
| Jaipur | ₹5,00,000 |
| Visakhapatnam | ₹5,00,000 |
| Madurai | ₹4,00,000 |
| Chandigarh | ₹5,00,000 |
| Ahmedabad | ₹5,00,000 |
| Gurugram | ₹10,00,000 |
Source: Milaap cancer campaign database, June 2026. Amounts reflect fundraising goals based on hospital treatment estimates at time of campaign creation.
Source: Milaap cancer campaign database, analysed June 2026. Amounts reflect fundraising goals based on hospital treatment estimates at time of campaign creation.
Here is what we make of these numbers.
Vellore’s high median of ₹8 lakh is driven almost entirely by CMC Vellore, a tertiary referral destination for complex cases from across South India. Families who reach CMC Vellore typically arrive after diagnosis at a local hospital, meaning their presentations tend to be more advanced and more complicated than what an average campaign represents.
Gurugram’s ₹10 lakh median reflects the premium hospital cluster in the Delhi NCR corridor, specifically Medanta, Max, and Fortis, which attract patients who either have corporate insurance or can afford premium care.
Madurai’s ₹4 lakh median reflects a combination of competitive hospital pricing and a strong government hospital presence. Families travelling to Madurai for cancer treatment tend to have less advanced presentations on average.
The ₹5 lakh figure that repeats across most cities is not a coincidence. It reflects a de facto treatment planning benchmark that oncologists across India appear to apply for first-line treatment of common cancers such as breast, blood, cervical, and head and neck cancers at a mid-tier private hospital. HCG’s 2026 city-wise chemotherapy benchmarking independently confirms that per-cycle costs in Tier 2 cities like Ahmedabad run 20 to 30% below metro equivalents, which is directionally consistent with what we see in our data.
Cancer Treatment Cost by Hospital: Our Data
| Hospital | Median treatment cost | Tier |
|---|---|---|
| Tata Memorial Hospital, Mumbai | ₹5,00,000 | Public / Aided |
| AIIMS (all campuses) | ₹5,00,000 | Government |
| Kidwai Memorial Institute, Bengaluru | ₹5,00,000 | Government |
| Cancer Institute (WIA) Adyar, Chennai | ₹5,00,000 | Aided |
| Homi Bhabha Cancer Hospital | ₹5,00,000 | TMC Network |
| Care Hospitals | ₹5,00,000 | Private |
| HCG Cancer Hospital | ₹5,00,000 | Private |
| Tata Medical Center, Kolkata | ₹6,00,000 | TMC Network |
| Narayana Health | ₹6,00,000 | Private |
| Omega Hospitals | ₹7,00,000 | Private |
| Basavatarakam Indo American, Hyderabad | ₹7,00,000 | Private |
| Apollo Hospital | ₹8,00,000 | Private |
| CMC Vellore | ₹8,00,000 | Aided |
| Manipal Hospital | ₹8,00,000 | Private |
| Rajiv Gandhi Cancer Institute, Delhi | ₹8,00,000 | Private |
| Fortis Hospital | ₹10,00,000 | Private |
| Max Hospital | ₹10,00,000 | Private |
| Medanta | ₹10,00,000 | Private |
Source: Milaap cancer campaign database, June 2026. Hospital names consolidated from raw campaign entries. For accreditation status refer to the NABH directory.
What stands out when we look at this data.
The gap between Tata Memorial (₹5 lakh) and Medanta (₹10 lakh) is not a gap in clinical outcomes. Tata Memorial is India’s premier cancer hospital, ranked among the best in Asia and home to the National Cancer Grid that sets evidence-based treatment protocols for the entire country. Families who choose Medanta over Tata Memorial are paying a 100% premium primarily for faster appointments, fewer queues, and private rooms.
CMC Vellore’s median of ₹8 lakh is higher than other aided institutions not because it charges more per procedure, but because the procedures required there tend to be more complex. It is a referral centre for cases that other hospitals could not resolve.
HCG and Care Hospitals come in at a ₹5 lakh median despite being private chains, which tells us they are effectively serving the middle segment of the market, above government hospitals in amenity but well below the premium chains on cost.
Government vs Private Hospital: An Honest Assessment
This is a choice that thousands of families who come to us have agonised over, and we want to give you our honest assessment based on what we have seen.
At a government or aided cancer hospital such as AIIMS, Tata Memorial, Kidwai, PGIMER, RCC Trivandrum, or Adyar Cancer Institute, the median cost in our data is ₹5 lakh or below. Drugs are sourced at regulated rates under the Drug Price Control Order. Chemotherapy protocols follow National Cancer Grid guidelines, which are evidence-based and do not involve upselling. Wait times for appointments and procedures can be 2 to 6 weeks, which is clinically acceptable for most cancer types. Room facilities are basic. The oncologists are, in many cases, among the most experienced in the country. All major government cancer centres are NABH-accredited, meaning they meet national standards for patient safety and clinical care.
At a premium private hospital such as Max, Medanta, Fortis, or Manipal, the median cost in our data is ₹8 to ₹10 lakh. Appointments are available within days. Rooms are private. Branded drugs are sometimes used where generics or biosimilars would be equally effective. Some facilities offer robotic surgery and proton therapy that government hospitals do not have.
Our assessment, based on three years of working with these campaigns: for most common cancers including breast, blood, head and neck, and cervical cancers, government and aided cancer hospitals deliver equivalent clinical outcomes at half the cost. If your cancer type requires a procedure only available at a private centre, or if a genuine medical reason makes wait times a risk, private care is justified. But we see too many families assume that private means better, and exhaust their resources on a cost premium that does not translate into a clinical advantage.
How Families in India Pay for Cancer Treatment
A landmark PubMed study on financial toxicity in Indian cancer patients found that cancer creates catastrophic health expenditure for the majority of Indian families, meaning treatment costs exceed 40% of total household income. In our experience at Milaap, that finding holds true today. The financial burden of cancer is not a side effect. It is a primary challenge that must be planned for before treatment begins, not after the first bill arrives.
Here is every funding avenue available to Indian cancer patients, in rough order from most to least accessible.
Health Insurance
If you have an existing health insurance policy, cancer treatment is typically covered, with important caveats. Most policies cover hospitalisation and surgery. Day-care chemotherapy has been covered by most insurers following IRDAI’s 2016 guidelines, but individual policy terms vary. Before treatment starts, check your policy specifically for: an oncology sub-limit (some policies cap cancer coverage at ₹3 to 5 lakh even if the overall sum assured is higher); pre-authorisation requirements for each chemotherapy cycle; whether immunotherapy and targeted therapy are covered (many policies exclude these as they are administered without formal hospitalisation).
If your insurer rejects a claim, request the rejection in writing. Many initial rejections are reversed on formal appeal.
Ayushman Bharat (PM-JAY)
Pradhan Mantri Jan Arogya Yojana covers cancer treatment up to ₹5 lakh per family per year at empanelled hospitals. Eligible families are those listed on the Socio-Economic Caste Census (SECC) database or the relevant state government scheme. Coverage includes surgery, chemotherapy, and radiation at government-empanelled private hospitals. PMJAY does not cover all hospitals. Verify empanelment before choosing a facility.
State Government Schemes
Several state governments have cancer-specific schemes that supplement PMJAY:
- Andhra Pradesh: NTR Vaidya Seva covers up to ₹25 lakh cashless per family per year at empanelled hospitals
- Rajasthan: Chief Minister Chiranjeevi Swasthya Bima Yojana covers cancer surgeries and chemotherapy
- Tamil Nadu: Chief Minister’s Comprehensive Health Insurance Scheme (CMCHIS) covers up to ₹5 lakh per year
- Karnataka: Arogyashri covers cancer treatment at government hospitals
- Maharashtra: Mahatma Jyotiba Phule Jan Arogya Yojana (MJPJAY) covers up to ₹3 lakh per year
Check your state health department’s website for current eligibility and empanelled hospital lists. Schemes change annually.
CGHS and ESI
If you or a family member is a central government employee, pensioner, or ESI-covered worker, cancer treatment at CGHS or ESI-empanelled hospitals is largely covered. Check the CGHS scheme list and your specific entitlement card for covered procedures.
PM National Relief Fund
The PM National Relief Fund (PMNRF) provides financial assistance to cancer patients in genuine hardship. Applications are made through the Prime Minister’s Office. Processing typically takes 4 to 8 weeks. It is not an automatic entitlement but merit-based assistance.
Hospital Financial Aid
Most major cancer hospitals in India, including Tata Memorial, Apollo, CMC Vellore, and HCG, have internal financial aid programmes for patients who cannot afford the full quoted amount. These are not widely advertised. At Tata Memorial, the Tata Memorial Centre Trust directly subsidises treatment costs for patients below a certain income threshold. Ask at the hospital’s social welfare desk or Medical Social Worker (MSW) office before assuming the full quoted amount must be paid. We have seen families pay far less than their initial quote once they engaged with the hospital’s aid programme.
NGO Support
Several NGOs specifically fund cancer treatment for low-income patients:
- Indian Cancer Society: treatment funds, free diagnostics, and support groups
- CanKids KidsCan: focused on paediatric cancers, provides treatment support and accommodation
- Cancer Patients Aid Association (CPAA): drugs, financial assistance, and legal support for insurance disputes
- Cuddles Foundation: nutrition support for child cancer patients
- Indian Association of Cancer Research: research and awareness funding
Medical Loans
Banks and NBFCs offer healthcare loans at 9 to 14% per annum for cancer treatment. Some hospitals have empanelled financiers who can process loans quickly. Be aware that the interest on a ₹5 lakh loan over 3 years adds approximately ₹80,000 to ₹1,20,000 in total repayment cost. Evaluate against other options before committing.
Crowdfunding on Milaap
Crowdfunding on Milaap is not a last resort. It is a legitimate, proven funding mechanism that works in parallel with insurance, PMJAY, and hospital aid, and one that over 43,000 cancer families have used. Campaigns typically raise 40 to 70% of their target from family, friends, colleagues, and Milaap’s community of regular donors.
The single biggest factor in campaign success is starting early, before treatment costs accumulate, and sharing the story with specificity. Campaigns that include a diagnosis letter, hospital quote, and a brief personal account consistently raise more than generic campaigns.
What the Hospital Quote Does Not Cover
The ₹5 lakh median in our data covers primary treatment. From three years of working with these campaigns, we know it typically does not cover several costs that families discover partway through treatment.
Travel and accommodation. Families travelling to a major cancer centre, such as Tata Memorial from Bihar or CMC Vellore from Kerala, spend ₹15,000 to ₹40,000 per month on travel, accommodation, and food. Over a 6-month chemotherapy course, this adds ₹90,000 to ₹2,40,000 to the real cost of treatment.
Lost income. When the patient or the primary caregiver stops working during treatment, the household income loss is a hidden cost that dwarfs the medical cost for many families we work with. According to India’s Periodic Labour Force Survey (PLFS), the average daily wage for an informal worker in India is approximately ₹350 to ₹550. A daily wage earner who cannot work for 6 months loses ₹60,000 to ₹90,000 in income, independent of any medical bill.
Post-treatment monitoring. CT scans, PET scans, and tumour markers form the surveillance protocol after active treatment ends. Each test costs ₹1,000 to ₹30,000 and the protocol continues for 3 to 5 years, following standard guidelines from the National Cancer Grid. These costs are almost never included in the initial hospital estimate or campaign amount.
Recurrence. According to WHO cancer data, many cancers recur after initial remission. The Indian Council of Medical Research (ICMR) reports that recurrence rates for common cancers in India range from 20% to 50% within 5 years depending on stage at diagnosis. A recurrence typically requires a new treatment protocol, sometimes more intensive and more expensive than the first, and a new funding effort from scratch.
We tell every family: raise more than you think you need at the start. It is far easier to withdraw unspent funds from a completed campaign than to return to your donor network a second time.
Frequently Asked Questions
Based on our dataset of 43000+ real campaigns, the median cancer treatment cost in India is ₹5 lakh. The average is ₹8.4 lakh, adjusted to remove data entry errors. Most families with early to mid-stage cancer need ₹2 to 8 lakh for primary treatment.
Madurai has the lowest median cost in our data at ₹4 lakh, driven by competitive pricing and a strong government hospital presence. Coimbatore, Varanasi, Patna, and Guwahati also show medians of ₹5 lakh with lower absolute costs than the metros.
Gurugram has the highest median at ₹10 lakh in our data, reflecting the premium hospital cluster (Medanta, Max, Fortis) that serves Delhi NCR patients.
No. Despite being India’s premier cancer hospital, Tata Memorial has a median campaign cost of ₹5 lakh in our data, the same as many mid-tier private hospitals. It is government-aided and subsidises treatment for low-income patients directly through the Tata Memorial Centre Trust.
Most health insurance policies cover hospitalisation-based cancer treatment. Day-care chemotherapy has been covered since IRDAI’s 2016 circular on standardisation of health insurance. Immunotherapy and targeted therapy coverage varies significantly by policy. Always check for oncology sub-limits before assuming full coverage.
Yes. PMJAY covers cancer surgery, chemotherapy, and radiation at empanelled hospitals up to ₹5 lakh per family per year. Advanced treatments like CAR-T therapy or proton therapy are not currently covered. Check eligibility and find empanelled hospitals at pmjay.gov.in.
A single chemotherapy cycle costs ₹15,000 to ₹2,00,000 depending on the drugs used. Conventional cytotoxic agents cost ₹15,000 to ₹40,000 per cycle. Targeted biologics cost ₹65,000 to ₹2,00,000. A full course of 6 to 8 cycles typically costs ₹2.5 to ₹25 lakh in total. See the HCG Oncology 2026 regimen guide for a protocol-level breakdown.
Conventional radiation costs ₹1.2 to ₹2.5 lakh for a full course. IMRT/IGRT costs ₹2.5 to ₹5 lakh. Proton therapy, available at Apollo Proton Cancer Centre and select others, costs ₹12 to ₹20 lakh.
Based on campaigns in our data, the median fundraising goal for treatment at AIIMS is ₹5 lakh. AIIMS subsidises treatment significantly for BPL patients. OPD consultation fees are nominal. Inpatient treatment is heavily subsidised at general ward rates.
Fully free treatment is available to eligible patients at certain government centres including Kidwai Memorial Institute in Bengaluru, RCC Trivandrum, and Chittaranjan National Cancer Institute in Kolkata, and through PMJAY at empanelled hospitals. Tata Memorial Hospital also subsidises or waives costs for patients who meet income criteria through the Tata Memorial Centre Trust.
The most effective approach is to combine sources: claim existing health insurance and PMJAY benefits first, then apply to the hospital’s financial aid programme, then contact NGOs like Indian Cancer Society and CPAA, then apply to the PM National Relief Fund, and simultaneously start a crowdfunding campaign on Milaap. Most families who manage the cost successfully use at least three of these in parallel.
Success Stories
Families Who Raised on Milaap
Hear directly from families who funded their treatment through crowdfunding
Interactive Tool
Cancer Treatment Cost Estimator
Based on Milaap data from 43,000+ real campaigns across India
Fill in all five fields above to see your estimated cost
Includes 35% buffer for
travel, recovery and follow-up
Start your fundraiser today. Zero platform fees on Milaap.
Start fundraiserThis estimate uses Milaap campaign data and published benchmarks. Actual costs vary by protocol, complications, and hospital. Always get a written cost estimate from your hospital before setting a fundraising goal.
Need Help Funding Your Cancer Treatment?
Our fundraising experts have helped 43000+ families launch and run successful cancer treatment campaigns. Book a free consultation today.
- Free 1:1 call with crowdfunding expert
- Campaign live in under 10 minutes
- 0% platform fee
- Dedicated fundraising manager assigned
Request a Free Callback
Our team will contact you shortly
🔒 Your details are 100% private & never shared
Need help raising funds for a medical emergency?
Start a fundraiser